Login / Signup

Once-Weekly Basal Insulin Fc Demonstrated Similar Glycemic Control to Once-Daily Insulin Degludec in Insulin-Naive Patients With Type 2 Diabetes: A Phase 2 Randomized Control Trial.

Juliana M Bue-ValleskeyChristof M KazdaChenchen MaJenny ChienQianyi ZhangEmmanuel ChigutsaWilliam LandschulzAxel HauptJuan P Frias
Published in: Diabetes care (2023)
Once-weekly BIF achieved excellent glycemic control similar to degludec, with no concerning hypoglycemia or other safety findings.
Keyphrases
  • glycemic control
  • type diabetes
  • blood glucose
  • weight loss
  • insulin resistance
  • double blind
  • open label
  • physical activity
  • clinical trial
  • phase iii
  • randomized controlled trial
  • placebo controlled